{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06246513",
            "orgStudyIdInfo": {
                "id": "SRP-9003-301"
            },
            "secondaryIdInfos": [
                {
                    "id": "2022-503112-17-00",
                    "type": "OTHER",
                    "domain": "Clinical Trials Information System (CTIS)"
                }
            ],
            "organization": {
                "fullName": "Sarepta Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 (EMERGENE)",
            "officialTitle": "A Phase 3 Multinational, Open-label, Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9003 in Subjects With Limb Girdle Muscular Dystrophy 2E/R4",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-trial-to-learn-more-about-an-experimental-gene-therapy-called-bidridistrogene-xeboparvovec-srp-as-a-possible-treatment-for-limb-girdle-muscular-dystrophy-emergene"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-11-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-30",
            "studyFirstSubmitQcDate": "2024-01-30",
            "studyFirstPostDateStruct": {
                "date": "2024-02-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sarepta Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multicenter, global study of the effects of a single systemic dose of SRP-9003 on beta-sarcoglycan (\u03b2-SG) gene expression in participants with limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4). This study will consist of both ambulatory participants (Cohort 1) and non-ambulatory participants (Cohort 2)."
        },
        "conditionsModule": {
            "conditions": [
                "Limb-girdle Muscular Dystrophy"
            ],
            "keywords": [
                "Limb Girdle Muscular Dystrophy Type 2E/R4",
                "LGMD2E/R4",
                "Pediatric",
                "SRP-9003",
                "scAAVrh74.MHCK7.hSGCB",
                "bidridistrogene xeboparvovec",
                "Non-ambulatory",
                "Ambulatory"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "SRP-9003",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive a single intravenous (IV) infusion of SRP-9003.",
                    "interventionNames": [
                        "Biological: SRP-9003",
                        "Drug: Glucocorticoid"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "SRP-9003",
                    "description": "Solution for single IV infusion",
                    "armGroupLabels": [
                        "SRP-9003"
                    ],
                    "otherNames": [
                        "scAAVrh74.MHCK7.hSGCB, bidridistrogene xeboparvovec"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Glucocorticoid",
                    "description": "Oral tablet (prophylactic)",
                    "armGroupLabels": [
                        "SRP-9003"
                    ],
                    "otherNames": [
                        "Prednisone or equivalent"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change from Baseline in \u03b2-SG Expression at Day 60 Post-dose as Measured by Immunofluorescence (IF) Percent \u03b2-SG Positive Fibers",
                    "timeFrame": "Baseline, Day 60"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change From Baseline in \u03b2-SG Expression at Day 60 Post-dose as Measured by Western Blot",
                    "timeFrame": "Baseline, Day 60"
                },
                {
                    "measure": "Change From Baseline Through Month 60 in North Star Assessment for Dysferlinopathy (NSAD) Total Score",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Change From Baseline Through Month 60 in Performance of Upper Limb Version 2.0 (PUL 2.0) Total Score",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Cohort 1: Change From Baseline Through Month 60 in the Time to Rise from the Floor Test",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Cohort 1: Change From Baseline Through Month 60 in the Time to Complete the 10-meter Walk/Run (10MWR) Test",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Cohort 1: Change From Baseline Through Month 60 in the Time to Ascend 4 Steps Test",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Cohort 1: Change From Baseline Through Month 60 in the Time to Complete the 100-meter Walk/Run (100MWR) Test",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Cohort 1: Change From Baseline Through Month 60 in the Timed Up and Go Test",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Change From Baseline Through Month 60 in Creatine Kinase Level",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Time to Change of Loss of Ambulation",
                    "timeFrame": "Baseline through Month 60"
                },
                {
                    "measure": "Change from Baseline in \u03b2-SG Expression at Day 60 Post-dose as Measured by IF Percent Fluorescent Expression",
                    "timeFrame": "Baseline, Day 60"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Cohort 1, only ambulatory participants:\n\n  * Able to walk without assistive aid\n  * 10-meter walk test (10MWT) \\<30 seconds\n  * NSAD \u226525\n* Cohort 2, only non-ambulatory participants:\n\n  * 10MWT \u226530 seconds or unable to perform\n  * PUL 2.0 entry scale score \u22653\n* Participants must possess 1 homozygous or 2 heterozygous pathogenic and/or likely pathogenic \u03b2-SG DNA gene mutations\n* Able to cooperate with muscle testing\n* Participants must have adeno-associated virus serotype rh74 (AAVrh74) antibody titers \\<1:400 (that is, not elevated) as determined by AAVrh74 antibody enzyme-linked immunosorbent assay.\n\nExclusion Criteria:\n\n* Left ventricular ejection fraction \\< 40% or clinical signs and/or symptoms of cardiomyopathy\n* Forced vital capacity \u226440% of predicted value and/or requirement for nocturnal ventilation\n* Diagnosis of (or ongoing treatment for) an autoimmune disease and on active immunosuppressant treatment\n* Presence of any other clinically significant illness or medical condition (other than LGMD2E/R4)\n\nOther inclusion/exclusion criteria apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "4 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sarepta Therapeutics Inc. For Clinical Trial Information, Select Option 4",
                    "role": "CONTACT",
                    "phone": "1-888-SAREPTA (1-888-727-3782)",
                    "email": "SareptAlly@sarepta.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Sarepta Therapeutics, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, San Diego-Altman Clinical and Translational Research Institute",
                    "status": "RECRUITING",
                    "city": "La Jolla",
                    "state": "California",
                    "zip": "92037",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "858-642-3704",
                            "email": "pshayesteh@health.ucsd.edu"
                        },
                        {
                            "name": "Chamindra Laverty, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.84727,
                        "lon": -117.2742
                    }
                },
                {
                    "facility": "Nationwide Childrens Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43215",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "614-722-5615",
                            "email": "delaney.gonzales@nationwidechildrens.org"
                        },
                        {
                            "name": "Anne Connolly, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "The Children's Hospital of Philadelphia",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "215-590-3807",
                            "email": "galals@chop.edu"
                        },
                        {
                            "name": "Susan Matesanz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Children's Hospital of The King's Daughter",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23507",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "757-668-9920",
                            "email": "proud.research@chkd.org"
                        },
                        {
                            "name": "Crystal Proud, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009136",
                    "term": "Muscular Dystrophies"
                },
                {
                    "id": "D000049288",
                    "term": "Muscular Dystrophies, Limb-Girdle"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020966",
                    "term": "Muscular Disorders, Atrophic"
                },
                {
                    "id": "D000009135",
                    "term": "Muscular Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12093",
                    "name": "Muscular Dystrophies",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26038",
                    "name": "Muscular Dystrophies, Limb-Girdle",
                    "asFound": "Limb Girdle Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12092",
                    "name": "Muscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4589",
                    "name": "Atrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "M22697",
                    "name": "Muscular Disorders, Atrophic",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "T3963",
                    "name": "Muscular Dystrophy",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3425",
                    "name": "Limb-girdle Muscular Dystrophy",
                    "asFound": "Limb Girdle Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3434",
                    "name": "Limb-girdle Muscular Dystrophy Type 2A",
                    "relevance": "LOW"
                },
                {
                    "id": "T3436",
                    "name": "Limb-girdle Muscular Dystrophy Type 2E",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011241",
                    "term": "Prednisone"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14121",
                    "name": "Prednisone",
                    "asFound": "Prospective",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "asFound": "Single Arm Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                }
            ]
        }
    },
    "hasResults": false
}